Effect of a modified regimen on drug-sensitive retreated pulmonary tuberculosis: A multicenter study in China

Author:

Ge Qiping,Ma Yan,Zhang Lijie,Ma Liping,Zhao Caiyan,Chen Yuhui,Huang Xuerui,Shu Wei,Chen Shengyu,Wang Fei,Li Bo,Han Xiqin,Shi Lian,Wang Xin,Li Youlun,Yang Shangpeng,Cao Wenli,Liu Qianying,Chen Ling,Wu Chao,Ouyang Bing,Wang Furong,Li Po,Wu Xiang,Xi Xiue,Leng Xueyan,Zhang Haiqing,Li Hua,Li Juan,Yang Chengqing,Zhang Peng,Cui Hongzhe,Liu Yuhong,Kong Chengcheng,Sun Zhaogang,Du Jian,Gao Weiwei

Abstract

Background and objectiveRetreatment pulmonary tuberculosis (PTB) still accounts for a large proportion of tuberculosis, and the treatment outcome is unfavorable. The recurrence of retreatment PTB based on long-term follow-up has not been well demonstrated. This study aimed to evaluate effect of a modified regimen on drug-sensitive retreated pulmonary tuberculosis.MethodsThis multicenter cohort study was conducted in 29 hospitals from 23 regions of China from July 1, 2009, to December 31, 2020. Patients were divided into two treatment regimen groups including experimental group [modified regimen (4H-Rt2-E-Z-S(Lfx)/4H-Rt2-E)]and control group [standard regimen (2H-R-E-Z-S/6H-R-E or 3H-R-E-Z/6H-R-E)]. The patients enrolled were followed up of 56 months after successful treatment. We compared the treatment success rate, treatment failure rate, adverse reaction rate, and recurrence rate between two regimens. Multivariate Cox regression model was used to identify the potential risk factors for recurrence after successful treatment with proportional hazards assumptions tested for all variables.ResultsA total of 381 patients with retreatment PTB were enrolled, including 244 (64.0%) in the experimental group and 137 (36.0%) in the control group. Overall, the treatment success rate was significant higher in the experimental group than control group (84.0 vs. 74.5%, P = 0.024); no difference was observed in adverse reactions between the two groups (25.8 vs. 21.2%, P > 0.05). A total of 307 patients completed the 56 months of follow-up, including 205 with the modified regimen and 102 with the standard regimen. Among these, 10 cases (3.3%) relapsed, including 3 in the experimental group and 7 in the control group (1.5% vs 6.9%, P = 0.035). Reduced risks of recurrence were observed in patients treated with the modified regimen compared with the standard regimen, and the adjusted hazard ratio was 0.19 (0.04–0.77).ConclusionThe modified retreatment regimen had more favorable treatment effects, including higher treatment success rate and lower recurrence rate in patients with retreated drug-sensitive PTB.

Publisher

Frontiers Media SA

Subject

Public Health, Environmental and Occupational Health

Reference27 articles.

1. Global tuberculosis report 2020,2020

2. Recurrent pulmonary tuberculosis after treatment success: a population-based retrospective study in China;Ruan;Clin Microbiol Infect.,2022

3. National survey of drug-resistant tuberculosis in China;Zhao;N Engl J Med.,2012

4. Risk of relapse and failure after retreatment with the Category II regimen in Nepal;Yoshiyama;Int J Tuberc Lung Dis.,2010

5. Five year review of treatment outcome of directly observed therapy (DOT) for re-treatment pulmonary tuberculosis patients in UCH,Ibadan,Nigeria;Ige;Afr J Med Med Sci.,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3